Halozyme Therapeutics
HALO
#1865
Rank
โ‚ฌ10.00 B
Marketcap
87,72ย โ‚ฌ
Share price
0.30%
Change (1 day)
44.09%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2026 (TTM): โ‚ฌ0.50 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are โ‚ฌ1.66 Billion. In 2025 the company made an earning of โ‚ฌ0.42 Billion a decrease over its 2024 earnings that were of โ‚ฌ0.50 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ0.50 B18.96%
2025 โ‚ฌ0.42 B-16.2%
2024 โ‚ฌ0.50 B59.94%
2023 โ‚ฌ0.31 B39.94%
2022 โ‚ฌ0.22 B0.16%
2021 โ‚ฌ0.22 B92.2%
2020 โ‚ฌ0.11 B-278.96%
2019 -โ‚ฌ65.85 Million-9.45%
2018 -โ‚ฌ72.72 Million-229.51%
2017 โ‚ฌ56.14 M-160.48%
2016 -โ‚ฌ92.83 Million216.03%
2015 -โ‚ฌ29.38 Million-52.86%
2014 -โ‚ฌ62.32 Million-18.09%
2013 -โ‚ฌ76.08 Million55.88%
2012 -โ‚ฌ48.81 Million169.94%
2011 -โ‚ฌ18.08 Million-63.44%
2010 -โ‚ฌ49.45 Million-7.19%
2009 -โ‚ฌ53.28 Million15.91%
2008 -โ‚ฌ45.97 Million83.89%
2007 -โ‚ฌ25 Million78.1%
2006 -โ‚ฌ14.04 Million16%
2005 -โ‚ฌ12.1 Million45.24%
2004 -โ‚ฌ8.33 Million682.42%
2003 -โ‚ฌ1.07 Million1659.12%
2002 -โ‚ฌ0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ17.06 B 3,109.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ6.34 B 1,094.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ31.68 B 5,860.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.09 B 1,235.08%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-โ‚ฌ0.18 Billion-132.06%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-โ‚ฌ44.34 Million-108.34%๐Ÿ‡บ๐Ÿ‡ธ USA